ArticleCancer management and research2019

Peptidylarginine deiminase 4 overexpression resensitizes MCF-7/ADR breast cancer cells to adriamycin via GSK3β/p53 activation.

Qianqian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.